Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Hypersalivation in children (Botulinum toxin type A - Hypersalivation in children)

Records returned : 7 (on 29 May 2025 at 10:56:29). Return to search results for ' Hypersalivation in children '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Botulinum toxin type A

Drug:

Botulinum toxin type A

Indication :

Hypersalivation in children

Status :

See narrative

Formulations :

Not Specified

Restrictions / Comments:

Important

Not assessed for formulary status. Contact pharmacy to make a formulary application.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD2

2. Glycopyrronium bromide

Drug:

Glycopyrronium bromide

Indication :

Hypersalivation in children

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Licensed in children 3 years and over. Expensive treatment option - consider an alternative. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Glycopyrronium bromide

Drug:

Glycopyrronium bromide

Indication :

Hypersalivation in children

Status :

Blue

Formulations :

Oral solution

Restrictions / Comments:

Important

1mg/5ml oral solution (sugar free). Licensed in children aged 3 years and over. NOTE - different strengths of liquid are not bioequivalent. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Glycopyrronium bromide

Drug:

Glycopyrronium bromide

Indication :

Hypersalivation in children

Status :

Blue

Formulations :

Oral solution

Restrictions / Comments:

Important

Oral solution 320mcg/ml (Sialanar brand). Expressed as 400mcg/ml. Licensed in children 3 years and over. NOTE - different strengths of liquid are not bioequivalent. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Hyoscine hydrobromide

Drug:

Hyoscine hydrobromide

Indication :

Hypersalivation in children

Status :

Blue

Formulations :

Patches
Tablets

Restrictions / Comments:

Important

Off-label use. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Hyoscine hydrobromide

Drug:

Hyoscine hydrobromide

Indication :

Hypersalivation in children

Status :

Blue

Formulations :

Oral solution
Oral suspension

Restrictions / Comments:

Important

300mcg/5ml. Unlicensed formulation. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Trihexyphenidyl hydrochloride

Drug:

Trihexyphenidyl hydrochloride

Indication :

Hypersalivation in children

Status :

Blue

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Important

Off-label use. 2nd-line option in children over 3 years. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC